<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Thyroid":10,
"papillary thyroid carcinoma":13,
"recurrence":5,
"total thyroidectomy":1,
"ultrasonography":3,
"Laryngeal cancer":2,
"Laryngeal function preservation":1,
"Partial laryngectomy":1,
"Surgery":3,
"Distant metastasis":1,
"Follicular thyroid carcinoma":2,
"Risk factor":3,
"Thick capsule":1,
"Tumor capsule":1,
"Differentiated thyroid cancer":4,
"intravoxel incoherent motion":1,
"magnetic resonance imaging (MRI)":1,
"parotid gland":1,
"radioiodine therapy":1,
"Sternotomy":1,
"Substernal goiter":1,
"Thyroidectomy":5,
"DNA methylation profiling":1,
"Follicular adenoma":1,
"Thyroid cancer":22,
"Thyroid nodules":1,
"EPIC":1,
"fruit juices":1,
"fruits":1,
"intake":1,
"vegetables":1,
"Subependymoma":1,
"hemorrhage":1,
"multiplicity":1,
"RET":2,
"ganglioneuromas":1,
"marfanoid":1,
"medullary thyroid cancer":3,
"pheochromocytoma":2,
"Cancer":8,
"Cancer registries":1,
"Population-based":1,
"Prognosis":5,
"Spain":1,
"Survival":4,
"Robotic thyroidectomy":2,
"Thyroid carcinoma":8,
"Transoral robotic thyroidectomy":1,
"Transoral thyroidectomy":2,
"30 mCi":1,
"50 mCi":1,
"radioactive iodine ablation":1,
"Clinicopathological characteristics":1,
"Papillary thyroid microcarcinoma":1,
"Variant":2,
"Familial":1,
"HABP2":1,
"Nonmedullary thyroid cancer":1,
"Thailand":1,
"epidemiology":1,
"head and neck":2,
"nasopharyngeal cancer":1,
"oral cancer":1,
"oropharyngeal cancer":1,
"Calcitonin":1,
"Calcium stimulation":1,
"Electrochemiluminescence immunoassay (ECLIA)":1,
"Male":1,
"Medullary thyroid carcinoma":2,
"Urinary iodine excretion":1,
"breast cancer":4,
"screening":2,
"hyperparathyroidism":1,
"multiple endocrine neoplasia":1,
"Bile duct":1,
"Gallbladder cancer":1,
"Lymph node dissection":1,
"Lymph node metastasis":3,
"3-dimensional ultrasound":1,
"contrast agents (clinical)":1,
"diagnostic efficiency":1,
"discrimination of malignant thyroid nodules":1,
"nodule-to-perinodule ratio":1,
"quantitative parameters of contrast-enhanced US time-intensity curve":1,
"receiver operating characteristic curve":1,
"statistics":1,
"thyroid/parathyroid":1,
"DNA-based screening":1,
"RET proto-oncogene":2,
"biochemical screening":1,
"gene carrier":1,
"gene test":1,
"multiple endocrine neoplasia type 2A":2,
"cell apoptosis":1,
"cell cycle":1,
"cell proliferation":1,
"gene silencing":1,
"hepatocellular carcinoma":1,
"features":1,
"malignancy":2,
"surgeon":1,
"ultrasound":6,
"colorectal cancer":2,
"immunohistochemistry":6,
"thyroid transcription factor-1":1,
"Bethesda":1,
"fine-needle aspiration":2,
"follicular neoplasm":1,
"follicular variant":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":2,
"papillary carcinoma":3,
"thyroid cytology":2,
"FNA":2,
"Zenker's":1,
"diverticulum":1,
"MEN2":2,
"immunity":1,
"tumor stroma":1,
"Bayesian maximum entropy":1,
"Industrial density":1,
"Integrative disease predictability":1,
"Socioeconomic status":1,
"differentiated thyroid carcinoma":3,
"highly sensitive":1,
"immunoassay":1,
"thyroglobulin":2,
"follow-up":1,
"major salivary gland carcinoma":1,
"population study":1,
"salivary gland carcinoma":1,
"second primary cancer":1,
"Wilms tumor":1,
"dosimetry":1,
"whole lung radiation":1,
"cytology":2,
"malignant pleural effusion":1,
"lateral neck metastases":1,
"neck dissection":3,
"neck levels":1,
"well-differentiated thyroid cancer":1,
"Akt":1,
"Growth":1,
"Invasion":3,
"Periostin":1,
"TSHR":1,
"lung metastasis":1,
"radioiodine":2,
"Active disease":1,
"Disease-free":1,
"Interleukins":1,
"Endoscopic thyroidectomy":1,
"Natural orifice transluminal endoscopic surgery":1,
"anaplastic thyroid carcinoma":3,
"clinical effect":1,
"lenvatinib":2,
"molecular-targeted therapy":1,
"tyrosine kinase inhibitor":1,
"contralateral occult carcinoma":1,
"Bethesda system":1,
"nondiagnostic":1,
"reporting":1,
"thyroid gland":2,
"thyroid nodule":4,
"Immunoglobulin G4":1,
"Warthin-like variant":1,
"Non-coding RNA":1,
"Transcriptional control":1,
"Tumor":1,
"Down syndrome":1,
"chronic conditions":1,
"late effects":1,
"leukemia":1,
"survivorship":1,
"Neoplasm metastasis":1,
"pancreatic neoplasms":1,
"thyroid hormones":3,
"triiodothyronine":2,
"triple negative breast neoplasms":1,
"FDG-PET":1,
"Head and neck oncology":1,
"Melanoma":2,
"Oncologic imaging":1,
"PET/MR Imaging":1,
"Squamous cell carcinoma":3,
"PET/CT":1,
"adenoma":2,
"choline":1,
"parathyroid":3,
"Nodular thyroid diseases":1,
"goitre":2,
"insulin resistance":1,
"metabolic syndrome":1,
"thyroid volume":1,
"MENX":1,
"p27 haploinsufficiency":1,
"BRAF":1,
"gene fusion":1,
"genetic landscape":1,
"diagnosis":2,
"lncRNAs":1,
"oncogene":1,
"papillary thyroid cancer":6,
"tumor suppressor":1,
"immunotherapy":1,
"molecularly targeted therapy":1,
"state-of-the-art":1,
"tumor models":1,
"Breast neoplasm":1,
"Logistic model":1,
"Metastasis":4,
"Ultrasonographic pattern":1,
"thyroid neoplasms":6,
"atrial fibrillation":1,
"cardiovascular diseases":1,
"follow-up studies":2,
"iodine radioisotopes":1,
"mortality":2,
"atypia of undetermined significance or follicular lesion of undetermined significance":1,
"follicular neoplasm or Hürthle cell neoplasm":1,
"diagnostic imaging":1,
"ionizing radiation":2,
"meta-analysis":3,
"radiation exposure":1,
"review":1,
"Fine needle aspiration of the thyroid":1,
"dynamic risk stratification":1,
"pediatrics":1,
"risk stratification":1,
"thyroid neoplasm":1,
"treatment outcome":1,
"lymph node":2,
"pediatric":1,
"atypia of undetermined significance/follicular lesion of undetermined significance":1,
"follicular neoplasm/suspicious for follicular neoplasm":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features":2,
"risk of malignancy":1,
"Doppler":1,
"NIFTP":1,
"noninvasive encapsulated follicular variant of papillary thyroid carcinoma":1,
"AKT3":1,
"TR4":1,
"clinical outcome":1,
"seminoma":1,
"Curcumin":2,
"EGCG, ATC":1,
"Genistein":1,
"Nutraceuticals":1,
"Resveratrol":2,
"Antigen retrieval":1,
"Hyalinizing trabecular tumour":1,
"Immunohistochemical staining":1,
"MIB-1":1,
"inferior laryngeal nerve":1,
"nonrecurrent laryngeal nerve":1,
"thyroid surgery":1,
"Childhood cancer/malignancy":1,
"Late/adverse effects":1,
"Surveillance":1,
"Survivors":1,
"Thyroid cancer/neoplasm":1,
"Multiple endocrine neoplasia 1":1,
"Parathyroid carcinoma":1,
"Primary hyperparathyroidism":1,
"Masaoka stage IVa":1,
"thymoma":1,
"Anti-thyroglobulin antibody":1,
"Circulating epithelial cells":1,
"Potential biomarker":1,
"anaplastic thyroid cancer":2,
"follicular thyroid cancer":1,
"immune checkpoint inhibitors":1,
"immunotherapies":1,
"ipilimumab":1,
"nivolumab":2,
"BRAF V600E mutation":1,
"Real time PCR":1,
"staging":1,
"exercise":1,
"hormone replacement therapy":1,
"immune":1,
"quality of life":1,
"hypothyroidism":1,
"immune thrombocytopenia":1,
"lung cancer":2,
"EMT":2,
"ING5":1,
"Proliferation":4,
"Clinical experience":1,
"Differentiated thyroid cáncer":1,
"Iodine-refractory":1,
"Tyrosine kinase inhibitors":1,
"Treatment costs":1,
"RET/PTC":1,
"medullary carcinoma":1,
"rearrangements":1,
"Alectinib (PubMed CID: 49806720)":1,
"Cabozantinib (PubMED CID: 25102847)":1,
"Catalytic spine":1,
"K/E/D/D":1,
"Lenvatinib (PubMED CID: 9823820)":1,
"Ponatinib (PubMED CID: 24826799":1,
"Protein kinase inhibitor classification":1,
"Protein kinase structure":1,
"Regulatory spine":1,
"Sorafenib (PubMED CID: 216239)":1,
"Sunitinib (PubMED CID: 5329102":1,
"Targeted cancer therapy":1,
"Vandetanib (PubMed CID: 3081361)":1,
"Dipeptidyl peptidase-IV":1,
"Gemigliptin":1,
"Metformin":1,
"Synergism":1,
"Quality of Life (QoL)":1,
"Bethesda V":1,
"cost analysis":1,
"frozen section":1,
"suspicious for malignancy":1,
"Hepatocellular carcinoma targeting":1,
"Lactoferrin":1,
"Liposomes":1,
"APC gene":1,
"methylation":1,
"promoter":1,
"autotransplantation":1,
"hypoparathyroidism":1,
"parathyroid gland":1,
"otter":1,
"pentastomiasis":1,
"tongue worm":1,
"Case–control study":1,
"Chernobyl fallout":1,
"Contaminated food":1,
"Dairy products":1,
"Leafy vegetables":1,
"antithyroglobulin antibodies":1,
"interference":1,
"Biomarker":1,
"Gastric cancer":2,
"Lymphocyte to monocyte ratio":1,
"Lateral compartment":1,
"carcinoma":3,
"genetic and molecular pathways":1,
"hyperplasia":1,
"multiple gland disease":1,
"sporadic primary hyperparathyroidism":1,
"Apoptosis":3,
"PDT":1,
"Ras":1,
"Sulforaphene":1,
"MEN2A":1,
"Outcomes":1,
"Prophylactic thyroidectomy":1,
"Distant metastases":1,
"Extrathyroidal extension":1,
"Multifocal":1,
"CSN6":1,
"FH535":1,
"Wnt/β-catenin signaling pathway":1,
"Drosophila":1,
"multiple endocrine neoplasia type 2":1,
"zebrafish":1,
"National Health Insurance":1,
"cohort study":1,
"dialysis":1,
"end-stage renal disease":1,
"Machine learning":1,
"Radiomics":1,
"Texture analysis":1,
"CCND2-AS1":1,
"LncRNA":1,
"PTC":1,
"Tumor staging":1,
"cytokeratin":1,
"esophageal cancer":1,
"lymph node micrometastasis":1,
"neoadjuvant chemoradiotherapy":1,
"randomized controlled trial":1,
"GOLPH3":1,
"nuclear inclusions":1,
"Acromegaly":1,
"Cushing syndrome":1,
"Hormones, ectopic":1,
"Inappropriate ADH syndrome":1,
"Positron emission tomography computed tomography":2,
"galectin-3":1,
"immuno-PET":1,
"thyroid FNA-cytology, tumor imaging in vivo":1,
"Gremlin1":1,
"Mutations":1,
"Endoscopy":1,
"Postoperative complications":1,
"autophagy":1,
"pseudolaric acid B":1,
"Lobular breast cancer":1,
"Metastases to thyroid":1,
"Core Needle Biopsy":1,
"Incidence":2,
"Papillary cancer":1,
"Cervical cancer":1,
"Early diagnosis":1,
"Pregnancy":1,
"Hematological malignancies":1,
"Long-term follow-up":1,
"Second malignancies":1,
"Stem-cell transplantation":1,
"Epithelial-mesenchymal transition":1,
"SNAI1":1,
"miR-199a-5p":1,
"Carcinoma, papillary":1,
"Handling strategy":1,
"Reasonable":1,
"Laryngeal Recurrence":1,
"Transoral Laser Microsurgery":1,
"C reactive protein":1,
"DNA methylation":1,
"Folate intake":1,
"Folate metabolism":1,
"Inflammation":1,
"Central lymph node dissection":1,
"Clinical lymph node negative":1,
"Lateral lymph node dissection":1,
"Breast carcinoma in situ":1,
"Breast neoplasms":1,
"SUV":1,
"Underestimation":1,
"cytokeratin-8":1,
"Suppurative thyroiditis":1,
"Thyroid abscess":1,
"Anti-oxidant":1,
"Nutraceutical":1,
"TPC-1 cells":1,
"Cancer progression":1,
"RRS1":1,
"Nonmedullary":1,
"True Familial":1,
"HMGB2":1,
"Warburg effect":1,
"hybrid imaging":1,
"SPECT/CT":1,
"miRNA-146a":1,
"microRNA":1,
"papillary thyroid carcinoma (PTC)":1,
"rs2910164":1,
"chemoprevention":1,
"thyroid tumorigenesis":1,
"TI-RADS":1,
"Gene networks":1,
"Gene set analysis":1,
"Modular organization":1,
"Node permutation":1,
"Random networks":1,
"Carcinoma of unknown primary":1,
"arterial dissections":1,
"cardiovascular":1,
"tyrosine-kinase inhibitors":1,
"Dual-specificity phosphatase 6":1,
"MAPK signaling":1,
"chemoresistance":1,
"chemoresponsiveness":1,
"CXCL12":1,
"CXCR4":1,
"CXCR7":1,
"FTC":1,
"oestrogen receptor-α":1,
"oestrogen receptor-β":1,
"Shanghai":1,
"temporal trend":1,
"medical occupational group":1,
"endocrine imaging":1,
"head and neck imaging":1,
"quantitative image analysis":1,
"sestamibi":1,
"solitary adenoma":1,
"computer-assisted":1,
"lymph nodes":1,
"pattern recognition":1,
"Demons registration":1,
"Hyperspectral imaging":2,
"digital histology":1,
"head and neck cancer surgery":1,
"cancer margin detection":1,
"convolutional neural network":1,
"deep learning":1,
"head and neck cancer":1,
"head and neck surgery":1,
"intraoperative imaging":1,
"local and pain control":1,
"radioresistant tumor":1,
"spinal metastases":1,
"spine SBRT":1,
"Neuroendocrine markers":1,
"TTF1":1,
"p40":1,
"DWI":1,
"DWI of solid parathyroid lesions":1,
"MRI":1,
"MRI findings solid parathyroid lesions":1,
"Solid parathyroid lesions":1,
"ROS":1,
"mesenchymal epithelial transition":1,
"nonsmall cell lung carcinoma":1,
"targeted therapy":1,
"Autofluorescence":1,
"Near infrared":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2018年2月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
